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Applicability to primary care of national clinical guidelines on blood
pressure lowering for people with stroke: cross sectional study
Jonathan Mant, Richard J McManus, Rachel Hare
Abstract
Objective To compare the characteristics of patients with
cerebrovascular disease in primary care with those of the
participants in the PROGRESS trial, on which national
guidelines for blood pressure lowering are based.
Design Population based cross sectional survey of patients with
confirmed stroke or transient ischaemic attack.
Setting Seven general practices in South Birmingham, England.
Participants All patients with a validated history of stroke
(n = 413) or transient ischaemic attack (n = 107).
Main outcome measures Patient characteristics: age, sex, time
since last cerebrovascular event, blood pressure, and whether
receiving antihypertensive treatment.
Results Patients were 12 years older than the participants in
PROGRESS and twice as likely to be women. The median time
that had elapsed since their cerebrovascular event was two and
a half years, compared with eight months in PROGRESS. The
systolic blood pressure of 315 (61%) patients was over 140 mm
Hg, and for 399 (77%) it was over 130 mm Hg. One hundred
and forty seven (28%) patients were receiving a thiazide
diuretic, and 136 (26%) were receiving an angiotensin
converting enzyme inhibitor.
Conclusions Important differences exist between the
PROGRESS trial participants and a typical primary care stroke
population, which undermine the applicability of the trial’s
findings. Research in appropriate populations is urgently
needed before the international guidelines are implemented in
primary care.
Introduction
International guidelines stress the importance of lowering blood
pressure in people who have had a stroke.1–4 In the United King-
dom, for example, the national clinical guidelines for stroke rec-
ommend a target blood pressure of 140/85 mm Hg and that
further lowering of blood pressure beyond this target should be
aimed for by using a thiazide diuretic and an angiotensin
converting enzyme inhibitor.1 The British Hypertension Society
guidelines are more aggressive, recommending a target blood
pressure of 130/80 mm Hg.2 The guidelines are heavily
influenced by the PROGRESS trial, which recruited people with
stroke from hospital settings.5 Despite some debate about the
implementation of these research findings regarding which
drugs should be used,6 a question that has been neglected is
whether these guidelines are relevant to primary care, which is
where most treatment of blood pressure occurs. We aimed to
compare the characteristics of people who have had a stroke in
primary care with those of the PROGRESS trial participants.
Methods
We recruited seven practices active in research from the South
Birmingham Primary Care Trust. The practices had a population
of 37 000 and were selected to represent both a range of practice
sizes and areas of low and high deprivation. The study
population comprised patients registered with these practices in
2002 who had had a confirmed stroke or transient ischaemic
attack. We identified possible participants from three sources:
general practice computer systems, a validated postal question-
naire to people aged 65 or over, and a search of a computer sys-
tem covering all hospital trusts in the South Birmingham area.7
We accepted a diagnosis of transient ischaemic attack as
confirmed if a specialist had made it. We accepted a diagnosis of
stroke as confirmed if it had been identified from at least two
sources or we found definite evidence of stroke in the patient’s
records. Data on last recorded blood pressure and prescribed
drugs came from the general practice computer systems.
Results
In this primary care population, 413 patients had a history of
confirmed stroke, and 107 patients had a history of confirmed
transient ischaemic attack (overall prevalence of cerebrovascular
disease 1.4%). The table shows the characteristics of these
patients compared with the participants in the PROGRESS trial.
In the primary care population, the proportion of women was
higher, patients were on average 12 years older, and they had
had their most recent cerebrovascular event about two years less
recently than the PROGRESS participants. Similar proportions
in the two populations had had a transient ischaemic attack but
no stroke. Systolic blood pressure was similar in the two popula-
tions, but the PROGRESS population had higher diastolic blood
pressure, a higher proportion with blood pressure ≥ 160/90 mm
Hg, and a lower proportion receiving antihypertensive drugs.
The systolic blood pressure of 63% (n = 315) of stroke
patients was above the 140 mm Hg target, and for 80% (399) of
patients it was over the British Hypertension Society 130 mmHg
target. Diastolic blood pressure was better controlled, with 58%
(290) of patients on or below the 80 mm Hg target. The blood
pressure of 81 (16%) patients was at or below the 130/80mmHg
target. Sixty eight per cent (352) of patients were receiving at
least one antihypertensive drug, and 35% (181) were receiving at
least two drugs. Twenty eight per cent (147) of patients were
receiving a thiazide diuretic, but only 1% (5) were receiving inda-
pamide. Similarly, 26% (136) of patients were receiving an angi-
otensin converting enzyme inhibitor, but only 2% (9) were on
perindopril. Forty four (8%) patients were receiving both an
angiotensin converting enzyme inhibitor and a thiazide diuretic.
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Discussion
The population with prevalent cerebrovascular disease in
primary care is very different from the participants in the
PROGRESS trial. Current practice is at variance with the guide-
lines. Patients taking part in clinical trials are well recognised to
be different from those seen in clinical practice. In many cases
this does not matter, but in the case of blood pressure lowering
after stroke it does, as the differences are so great as to
undermine the applicability of the research to primary care. The
high mean age of patients with a history of cerebrovascular dis-
ease in primary care is a cause for concern: over the age of 80,
reduction in risk of stroke through lowering blood pressure may
be offset by an increase in mortality.8 The longer time lapse since
the most recent cerebrovascular event in patients in primary care
is also important, as risk of recurrence declines over time,9 and
the harm to benefit ratio from aggressive treatment becomes less
favourable.
A particular strength of this study is that, although drawn
from primary care, only patients in whom the diagnosis of
cerebrovascular disease had been validated were included. This
side steps the problem that recording of cerebrovascular disease
on computer in primary care is prone to error with respect to
both false positive and false negative diagnoses.7
The population is also representative: South Birmingham
has similar demographics and mortality from stroke to England
and Wales as a whole. Sixteen per cent of the study population
were over the age of 65, which is the same proportion as the
national average10; the stroke mortality for this area (2.36/10 000
aged under 75) is similar to the national rate (2.56/10 000).10 11
Other studies confirm that the “typical” stroke patient in general
practice is very different from the PROGRESS study population.
The health survey for England reported that only 17% of people
with stroke had had the event within the previous year,12 and
analysis of the general practice research database showed that
52% of prevalent stroke cases are in women.13 No previous stud-
ies of prevalent stroke have reported mean age, but in the
general practice research database analysis 48% of people with
stroke were over the age of 75,13 and in the OXVASC study 52%
of first strokes were in people over the age of 75.14
As the practices selected were active in research, blood pres-
sure control in these practices may be better than in the UK as a
whole. Our analysis was based on the latest blood pressure
recorded in the general practice records. This will have reflected
several recordings of blood pressure in some cases and a single
reading in other instances. This may have resulted in an overesti-
mation of “true” blood pressure in this stroke population
compared with measurements in the controlled setting of a
study, but these are the readings on which management will be
decided.
Current national and international guidelines may give
appropriate advice for the management of blood pressure of
younger patients who have had a recent cerebrovascular event.
Unfortunately, these guidelines may act as an impediment to fur-
ther research. We would urge that further evidence should be
collected on the efficacy and adverse effects of intensive blood
pressure lowering in representative populations before we
implement this guidance in primary care.
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Characteristics of patients in primary care with history of cerebrovascular
disease and participants of PROGRESS trial
Characteristics
Primary care (n=520) PROGRESS trial
(n=6105)Value 95% CI
Mean (SD) age (years) 76 (10) 75 to 77 64 (10)
Median (IQR) time since
last event (years)
2.5 (1-8)* 0.7 (0.2-1.75)
% (No) women 54 (282) 50 to 58 30
% (No) with history of TIA
only
21 (107) 17 to 24 22
Mean (SD) systolic BP
(mm Hg)
148† (21) 147 to 150 147 (19)
Mean (SD) diastolic BP
(mm Hg)
80† (12) 79 to 81 86 (11)
% (No) with hypertension
(BP≥160/90 mm Hg)
38 (188)† 34 to 42 48
% (No) receiving
antihypertensive
treatment
68 (352) 64 to 72 50
BP=blood pressure; IQR=interquartile range; TIA=transient ischaemic attack.
*Data available for 419 (81%) patients.
†No blood pressure reading for 23 patients.
What is already known on this topic
National and international guidance emphasises the
importance of lowering blood pressure in people with a
history of cerebrovascular disease, largely on the basis of
the results of the PROGRESS trial
The applicability of the findings of PROGRESS to primary
care is uncertain
What this study adds
Important differences exist between the participants in
PROGRESS and a typical primary care population of
people with cerebrovascular disease, undermining the
applicability of the research findings
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